Market Research Logo

United States Disposable Hospital Supplies Market Outlook to 2021

United States Disposable Hospital Supplies Market Outlook to 2021

Summary

GlobalData’s new report, United States Disposable Hospital Supplies Market Outlook to 2021, provides key market data on the United States Disposable Hospital Supplies market. The report provides value, in millions of US dollars, volume (in units) and average price data (in US dollars), within market segments - Procedure Kits and Trays, Gloves, Drapes, Gowns and Feeding Tubes.

The report also provides company shares and distribution shares data for the market category, and global corporate-level profiles of the key market participants. Based on the availability of data for the particular category and country, information related to pipeline products, news and deals is available in the report.

Extensive interviews are conducted with key opinion leaders (KOLs), physicians and industry experts to validate the market size, company share and distribution share data and analysis.

Scope

  • Market size for Disposable Hospital Supplies market segments - Procedure Kits and Trays, Gloves, Drapes, Gowns and Feeding Tubes.
  • Annualized market revenues (USD million), volume (units) and average selling price ($) data for each of the market categories. Data is provided from 2007 to 2014 and forecast to 2021.
  • 2014 company shares and distribution shares data for Disposable Hospital Supplies market.
  • Global corporate-level profiles of key companies operating within the United States Disposable Hospital Supplies market.
  • Key players covered include Cardinal Health, Inc., 3M Health Care Ltd., Halyard Health, Inc., Covidien plc and others.
Reasons to buy
  • Develop business strategies by identifying the key market segments poised for strong growth in the future.
  • Develop market-entry and market expansion strategies.
  • Design competition strategies by identifying who-stands-where in the market.
  • Develop investment strategies by identifying the key market segments expected to register strong growth in the near future.
  • What are the key distribution channels and what’s the most preferred mode of product distribution - Identify, understand and capitalize.


1 Table of Contents
1.1 List of Tables
1.2 List of Figures
2 Introduction
2.1 What Is This Report About?
2.2 Disposable Hospital Supplies Market Segmentation
2.3 Definitions of Markets Covered in the Report
3 Disposable Hospital Supplies Market, United States
3.1 Disposable Hospital Supplies Market, United States, Revenue ($m), 2007-2014
3.2 Disposable Hospital Supplies Market, United States, Revenue ($m), 2014-2021
3.3 Disposable Hospital Supplies Market, United States, Volume (Units), 2007-2014
3.4 Disposable Hospital Supplies Market, United States, Volume (Units), 2014-2021
3.5 Disposable Hospital Supplies Market, United States, Average Price ($), 2007-2021
3.6 Disposable Hospital Supplies Market, United States, Distribution Share by Revenue ($m), 2013-2014
3.7 Disposable Hospital Supplies Market, United States, Company Share by Revenue ($m), 2014
4 Overview of Key Companies in United States, Disposable Hospital Supplies Market
4.1 Cardinal Health, Inc.
4.1.1 Company Overview
4.2 3M Health Care Ltd.
4.2.1 Company Overview
4.3 Halyard Health, Inc.
4.3.1 Company Overview
4.4 Medline Industries, Inc.
4.4.1 Company Overview
4.5 Molnlycke Health Care AB
4.5.1 Company Overview
4.6 Covidien plc
4.6.1 Company Overview
5 Financial Deals Landscape
5.1 Acquisition
5.1.1 Stryker to Acquire Sage Products from Madison Dearborn Partners for USD2.8 Billion
5.1.2 NN Completes Acquisition of Precision Engineered Products from Jordan Company and Nautic Partners for USD615 Million
5.1.3 Danaher Acquires Pall for USD13.8 Billion
5.1.4 Cardinal Health Acquires Metro Medical Supply
5.2 Debt Offerings
5.2.1 Invacare Prices Private Placement of 5% Notes Due 2021 for USD130 Million
5.3 Equity Offerings
5.3.1 Integra LifeSciences Raises USD220 Million in Public Offering of Shares
5.3.2 Integra LifeSciences Prices Public Offering of Shares for USD201.3 Million
5.4 Private Equity
5.4.1 Third Point Acquires 7% Stake in Baxter International
5.5 Venture Financing
5.5.1 Vestagen Technical Textiles Raises USD7 Million in Venture Financing
5.5.2 Eccrine Systems Raises USD1.5 Million in Seed Financing
6 Recent Developments
6.1 Corporate Communications
6.1.1 Jan 13, 2016: Command Medical Products Hires John Walter as Director of New Business Development
6.1.2 Nov 20, 2015: Marc Gibeley Joins Board of Directors of Invacare
6.1.3 Oct 28, 2015: SteadyMed Announces Positive Clinical Study Results in Support of SMT-201 for the Treatment of Post Surgical Pain in the Home Setting
6.1.4 Oct 28, 2015: Baxter Names José Almeida Chairman and CEO
6.1.5 Oct 27, 2015: Baxter To Reduce Workforce
6.1.6 Oct 26, 2015: Michael Bruch Appointed Chief Financial Officer of Cesca Therapeutics
6.1.7 Oct 21, 2015: Baxter Appoints Michael F. Mahoney to Its Board
6.1.8 Oct 15, 2015: Actinium Announces Completion of the Fourth and Final Cohort of Its Actimab-A Trial
6.1.9 Sep 30, 2015: Baxter Appoints Munib Islam to Board; Announces Agreement with Third Point
6.1.10 Sep 29, 2015: Anacor Pharmaceuticals Announces Presentations of Crisaborole Topical Ointment, 2% Phase 3 Pivotal Data at Two Upcoming Medical Conferences
6.1.11 Sep 28, 2015: Ken Harris to Step Down as President of Cesca Therapeutics
6.1.12 Sep 15, 2015: Cesca Therapeutics Announces Restructuring Initiative
6.1.13 Sep 11, 2015: Owens & Minor Names W. Marshall Simpson as Executive Vice President & Chief Commercial Officer
6.1.14 Aug 27, 2015: Spectranetics Names Stacy McMahan Chief Financial Officer
6.1.15 Jul 09, 2015: SonaCare Medical Sells Prostate Ablation System with MRI/Ultrasound Image Fusion to Heidelberg Prostate Clinic
6.1.16 Jun 19, 2015: Mal Mixon to Retire from Invacare Board of Directors
6.1.17 Jun 12, 2015: Cesca Therapeutics Board of Directors Appoint Robin C. Stracey as Chief Executive Officer
6.1.18 May 20, 2015: Owens & Minor Names P. Cody Phipps President & Chief Executive Officer, Effective July 1
6.1.19 May 14, 2015: Bellicum Announces Clinical Study Results Published in BLOOD and Featured in Late-Breaking Session at ASGCT Annual Meeting
6.1.20 May 14, 2015: Invacare Adds Two New Board Members
6.1.21 May 04, 2015: Cesca Therapeutics Announces Changes in Management
6.1.22 Apr 30, 2015: Integra LifeSciences Names Keith Valentine as Chief Executive Officer of SeaSpine; John Bostjancic Appointed as Chief Financial Officer of SeaSpine
6.1.23 Mar 12, 2015: Spectranetics Appoints Todd C. Schermerhorn as Director
6.1.24 Mar 05, 2015: Study Shows Castle Biosciences’ Noninvasive Skin Melanoma Gene Test Improves Accuracy of Sentinel Lymph Node Biopsy in Predicting Metastasis
6.1.25 Mar 04, 2015: Hill-Rom Elects Stacy Enxing Seng to its Board of Directors
6.1.26 Mar 02, 2015: Alize Pharma launches Phase II clinical trial of AZP-531 in Prader-Willi syndrome
6.1.27 Feb 24, 2015: Command Medical Products Announces Executive Promotion
6.2 Financial Announcements
6.2.1 Feb 16, 2016: Cesca Therapeutics Reports Second Quarter Fiscal 2016 Results and Provides a Status Update to Investors
6.2.2 Feb 11, 2016: Invacare Announces Financial Results for the Quarter and Year Ended December 31, 2015
6.2.3 Feb 08, 2016: Owens & Minor Reports 4th Quarter & Full-Year 2015 Financial Results
6.2.4 Feb 02, 2016: Baxter Announces Fourth Quarter Results and Provides 2016 Financial Outlook
6.2.5 Feb 01, 2016: Hill-Rom Reports Strong First Quarter Results Exceeding Previous Guidance and Increases Full Year Earnings Outlook
6.2.6 Jan 27, 2016: Sharps Compliance Reports Record Customer Billings of $10.5 Million for the Second Quarter of Fiscal 2016
6.2.7 Jan 12, 2016: Hill-Rom Reports Preliminary Fiscal First Quarter Revenue
6.2.8 Dec 07, 2015: Leading HIFU Expert Begins U.S.-Based Program With Treatment Of First Prostate Cancer Patients
6.2.9 Nov 25, 2015: Pall Reports First Quarter Results
6.2.10 Nov 23, 2015: AdvanSource Biomaterials Reports Fiscal 2016 Second Quarter Results and Third Consecutive Quarterly Profit
6.2.11 Nov 16, 2015: Vigilant Biosciences Receives CE Mark for OncAlertTM Oral Cancer CD44/Total Protein LAB Test to Aid in Diagnosis of Oral Cancer
6.2.12 Nov 16, 2015: Leviticus Cardio Achieves Successful Transcutaneous Coplanar Energy Transfer in Chronic Animal Model
6.2.13 Nov 16, 2015: Cesca Therapeutics Reports First Quarter Fiscal Year 2016 Financial Results
6.2.14 Nov 15, 2015: ERBA to Launch LISA XL System in Europe and International Markets; Product to be Featured at MEDICA 2015
6.2.15 Nov 13, 2015: Lumenis Expands Its Portfolio of Gynecology Solutions with the New UltraPulse DUO for Fertility-Related Disorders and FemTouch for Improved Vaginal Health
6.2.16 Nov 12, 2015: In New Study EMMA Capnograph Has Comparable Accuracy to Sidestream Capnography Against Gold-Standard Blood Gas Analysis
6.2.17 Nov 05, 2015: Hill-Rom Reports Strong Fourth Quarter and Full-Year Results Exceeding Previous Guidance
6.2.18 Nov 03, 2015: Integra LifeSciences Reports Third Quarter 2015 Financial Results
6.2.19 Oct 30, 2015: Licensee's drug to commence Phase 2 and Phase 3 trials
6.2.20 Oct 29, 2015: Neuren Completes Enrolment in “INTREPID” Clinical Trial
6.2.21 Oct 28, 2015: New Study Bolsters Cologuard’s Performance in Detecting Colorectal Cancer and Ability to Improve Access to Screening
6.2.22 Oct 28, 2015: Sharps Compliance Fiscal 2016 First Quarter Revenue Increases 12% to $7.9 Million
6.2.23 Oct 27, 2015: Baxter Reports Strong Third Quarter Financial Results Exceeding Previously Issued Guidance
6.2.24 Oct 27, 2015: Owens & Minor Releases 3rd Quarter 2015 Financial Results
6.2.25 Oct 22, 2015: Spectranetics Achieves Third Quarter 2015 Revenue of $61.7 Million
6.2.26 Oct 22, 2015: Invacare Announces Financial Results for the Third Quarter and Nine Months of 2015
6.2.27 Oct 15, 2015: ConvaTec: Third Quarter 2015 Report
6.2.28 Oct 08, 2015: Allergan To Present Data On Anti-Infective Drug AVYCAZ at IDWeek 2015
6.2.29 Sep 30, 2015: Zogenix Reports Positive Top-Line Results From Relday Phase 1b Multi-Dose Clinical Trial
6.2.30 Sep 29, 2015: Motif Announces Presentation of Two Posters on Iclaprim at ID Week 2015
6.2.31 Sep 17, 2015: Cesca Therapeutics Reports Fiscal Year 2015 Results
6.2.32 Aug 27, 2015: RedHill Biopharma Receives Notice of Allowance for New Israeli Patent Covering RHB-104 for the Treatment of Crohn's Disease
6.2.33 Aug 20, 2015: AdvanSource Biomaterials Reports Fiscal 2016 First Quarter Results and Second Consecutive Quarterly Profit
6.2.34 Aug 12, 2015: Sharps Compliance Fiscal 2015 Fourth Quarter Revenue Increases 27% To $9.0 Million; Customer Billings Increase 28% to $9.4 Million
6.2.35 Aug 11, 2015: Command Medical Products Announces Promotion to Vice President
6.2.36 Aug 07, 2015: Hill-Rom Reports Strong Third Quarter Results; Updates 2015 Adjusted Earnings Outlook
6.2.37 Jul 30, 2015: Integra LifeSciences Reports Second Quarter 2015 Financial Results
6.2.38 Jul 29, 2015: Baxter Reports Strong Second Quarter Financial Results Exceeding Guidance
6.2.39 Jul 29, 2015: Hospira Reports Second-Quarter 2015 Results
6.2.40 Jul 27, 2015: Owens & Minor Releases 2nd Quarter 2015 Financial Results
6.2.41 Jul 23, 2015: Invacare Announces Financial Results for the Second Quarter and First Six Months of 2015
6.2.42 Jul 23, 2015: Spectranetics Reports Second Quarter Financial Results
6.2.43 Jul 15, 2015: Newest FDA-Cleared Breakthrough In Women's Health Treatments Provided at the Healthcare Practice of Lizellen La Follette, MD
6.2.44 Jul 15, 2015: ConvaTec: Second Quarter 2015 Report
6.2.45 Jul 14, 2015: NorthShore University HealthSystem Becomes First in Illinois to Install Revolutionary Neurological Operating System
6.2.46 Jul 13, 2015: Study Demonstrates Accuracy of GlySure Continuous Intravascular Glucose Monitoring System in Critically Ill Patients
6.2.47 Jun 23, 2015: Cesca Therapeutics Reports Third Quarter Fiscal 2015 Results
6.2.48 May 21, 2015: Pall Reports Third Quarter Results
6.2.49 May 05, 2015: Hill-Rom Reports Second Quarter Results Ahead Of Guidance; Increases 2015 Adjusted Earnings Outlook
6.2.50 Apr 30, 2015: Integra LifeSciences Reports First Quarter 2015 Financial Results
6.2.51 Apr 28, 2015: Hospira Reports First-Quarter 2015 Results
6.2.52 Apr 27, 2015: Medtronic Announces Consent Decree with FDA for the Synchromed Drug Infusion System
6.2.53 Apr 27, 2015: Owens & Minor Reports 1st Quarter 2015 Financial Results
6.2.54 Apr 23, 2015: Spectranetics Achieves First Quarter 2015 Revenue of $57.4 Million
6.2.55 Apr 23, 2015: Invacare Announces Financial Results for the First Quarter of 2015
6.2.56 Apr 23, 2015: Baxter Reports First Quarter Financial Results That Exceed Guidance
6.2.57 Apr 16, 2015: Arch Therapeutics' AC5 Compared Favorably vs. Commercially Available Combination Hemostat in Animal Study
6.2.58 Apr 15, 2015: ConvaTec: First Quarter 2015 Report
6.2.59 Apr 07, 2015: Positive Clinical Data for iCAD's Xoft System to be Highlighted at American Brachytherapy Society Annual Meeting
6.2.60 Mar 30, 2015: BRILINTA receives US FDA approval for new administration option
6.2.61 Mar 06, 2015: TSO3 to showcase its STERIZONE VP4 Sterilizer at AORN Surgical Conference and Expo 2015
6.2.62 Mar 06, 2015: TSO3 Enters Into First Commercial Agreement For Sterizone Vp4 Sterilizer
6.2.63 Mar 04, 2015: Illumina Launches TruSight HLA Solution
6.2.64 Feb 25, 2015: NICE guidance recommends simeprevir for treating hepatitis C
6.2.65 Feb 24, 2015: Integra LifeSciences Reports Fourth Quarter 2014 Financial Results
6.3 Government and Public Interest
6.3.1 Jul 14, 2015: Malaysia, The Hub Of Medical Device Manufacturing In Asean
6.4 Legal And Regulatory
6.4.1 May 01, 2015: Hospira Statement On FDA's Final Biosimilar Guidance Documents
6.4.2 Apr 17, 2015: Regarding the Result of Inspection at Terumo CVS Ann Arbor Plant
6.4.3 Apr 13, 2015: Hope for Greater Access for Patients to Biosimilar Medicines
6.4.4 Feb 27, 2015: Hospira Provides Update On FDA Inspection At Its Facilities In US And India
6.5 Other Significant Developments
6.5.1 Jan 06, 2016: FONAR Management Subsidiary HMCA Adds 25th MRI Center
6.5.2 Dec 28, 2015: Tennessee Health Management Selects Medline as Exclusive Distribution Partner in $4 Million Prime Vendor Deal
6.5.3 Nov 17, 2015: Medline to Provide Robust Product Portfolio and Strategic Tools to More Than 200 Physician Offices Through New $9 Million Prime Vendor Agreement
6.5.4 Sep 28, 2015: Esperion Therapeutics Provides Further Updates on ETC-1002 Global Phase 3 Strategy Following Receipt of End-of-Phase 2 Meeting Minutes
6.5.5 Sep 15, 2015: Medline Secures Exclusive Distribution Partnership with OSF HealthCare in $250 Million Prime Vendor Deal
6.5.6 Sep 11, 2015: Pall Ilfracombe, UK Manufacturing Facility Wins Gold at the 2015 RoSPA Occupational Health and Safety Awards
6.5.7 Aug 25, 2015: Jhpiego and Johns Hopkins Center for Bioengineering Innovation & Design Selected as Finalist for 2015 INDEX: Award
6.5.8 Mar 30, 2015: Baxter Expands Access to Healthcare Through Collaborations and Charitable Giving
6.5.9 Mar 26, 2015: Medline to Provide American Academy of Orthopaedic Surgeons Members Significant Cost-Savings, Clinical and Quality Assurance Solutions through New Preferred Supplier Agreement
6.5.10 Mar 04, 2015: Hill-Rom Declares Second Quarter 2015 Dividend
6.6 Product News
6.6.1 Jan 26, 2016: Baxter initiates Voluntary Nationwide Recall of Select Lots of IV Solutions Due to the Potential for Leaking Containers and Particulate Matter
6.7 Strategy And Business Planning
6.7.1 Jan 14, 2016: Scrutiny of Essure Increases as Women Come Forward Claiming Permanent Injuries
6.7.2 Nov 12, 2015: Baxter Completes Capacity Expansion at Halle, Germany Facility to Support BioPharma Solutions’ Oncology Contract Manufacturing Services
6.7.3 Oct 15, 2015: Baxter International expanding operations in Mountain Home
6.7.4 Sep 28, 2015: Clinical Data Presented On Binimetinib And Encorafenib In Melanoma
6.7.5 Jul 07, 2015: PrenaTest is now reimbursed by Swiss statutory health insurance programs
6.7.6 Jul 01, 2015: Integra LifeSciences Completes Spin-Off of SeaSpine
6.7.7 May 18, 2015: Baxter and Baxalta Highlight Business Strategies at Investor Conference
6.7.8 Apr 01, 2015: Integra LifeSciences Announces the Filing of the Form 10 Registration Statement for the Planned Spin-off of the Orthobiologics and Spinal Fusion Hardware Business, SeaSpine
7 Appendix
7.1 Research Methodology
7.1.1 Coverage
7.1.2 Secondary Research
7.1.3 Primary Research
7.1.4 Company Share Analysis
7.1.5 Distribution Share Analysis
7.2 GlobalData Consulting
7.3 Contact Us
7.4 Disclaimer
1.1 List of Tables
Table 1: Disposable Hospital Supplies Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
Table 2: Disposable Hospital Supplies Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
Table 3: Disposable Hospital Supplies Market, United States, Volume (Units), Historic, 2007-2014
Table 4: Disposable Hospital Supplies Market, United States, Volume (Units), Forecast, 2014-2021
Table 5: Disposable Hospital Supplies Market, United States, Average Price ($), Historic, 2007-2014
Table 6: Disposable Hospital Supplies Market, United States, Average Price ($), Forecast, 2014-2021
Table 7: Disposable Hospital Supplies Market, United States, Distribution Share by Revenue ($m), USD Constant, 2013-2014
Table 8: Disposable Hospital Supplies Market, United States, Company Share by Revenue ($m), USD Constant, 2014
Table 9: Stryker to Acquire Sage Products from Madison Dearborn Partners for USD2.8 Billion
Table 10: NN Completes Acquisition of Precision Engineered Products from Jordan Company and Nautic Partners for USD615 Million
Table 11: Danaher Acquires Pall for USD13.8 Billion
Table 12: Cardinal Health Acquires Metro Medical Supply
Table 13: Invacare Prices Private Placement of 5% Notes Due 2021 for USD130 Million
Table 14: Integra LifeSciences Raises USD220 Million in Public Offering of Shares
Table 15: Integra LifeSciences Prices Public Offering of Shares for USD201.3 Million
Table 16: Third Point Acquires 7% Stake in Baxter International
Table 17: Vestagen Technical Textiles Raises USD7 Million in Venture Financing
Table 18: Eccrine Systems Raises USD1.5 Million in Seed Financing
1.2 List of Figures
Figure 1: Disposable Hospital Supplies Market, United States, Revenue ($m), USD Constant, Historic, 2007-2014
Figure 2: Disposable Hospital Supplies Market, United States, Revenue ($m), USD Constant, Forecast, 2014-2021
Figure 3: Disposable Hospital Supplies Market, United States, Volume (Units), Historic, 2007-2014
Figure 4: Disposable Hospital Supplies Market, United States, Volume (Units), Forecast, 2014-2021
Figure 5: Disposable Hospital Supplies Market, United States, Company Share (%) 2014

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Share this report